The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the “prodromal” sample

✍ Scribed by T.J. Miller; R.B. Zipursky; D. Perkins; J. Addington; S.W. Woods; K.A. Hawkins; R. Hoffman; A. Preda; I. Epstein; D. Addington; S. Lindborg; E. Marquez; M. Tohen; A. Breier; T.H. McGlashan

• Book ID: 119555015
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 265 KB
• Volume: 61
• Category: Article
• ISSN: 0920-9964
• DOI: 10.1016/s0920-9964(02)00440-1